/explore
|
You are here 
|
dmso.org | ||
| | | | |
diabetesjournals.org
OBJECTIVE. Glucose-dependent insulinotropic polypeptide (GIP), unlike glucagon-like peptide (GLP)-1, lacks glucose-lowering properties in patients with type 2 d |
|
| | | | | ||
| | | | |
www.jci.org
[AI summary] The provided text is a compilation of numerous scientific articles and studies, primarily focused on obesity, diabetes, and related metabolic disorders. The research spans a wide range of topics, including the role of gut hormones like GLP-1 and PYY in regulating food intake and glucose metabolism, the mechanisms of action of various drugs and peptides, and their therapeutic applications in managing metabolic diseases. Key areas of focus include the use of GLP-1 receptor agonists for weight loss and glycemic control, the potential of dual agonists targeting multiple receptors, and the exploration of endocrine signals such as GDF15 in nutritional stress. Additionally, the text touches on the physiological and pharmacological aspects of these inte... |
|
| | | | | ||
| | | | |
www.frontiersin.org
Interest in the use of anticholinergics for preventing the development of epilepsy after traumatic brain injury (TBI) has grown since recent basic studies sh... |
|
| | | | | ||
| | | | |
wholehealthsource.blogspot.com
[2013 update. I'm leaving this post up for informational purposes, but I think it's difficult to determine the "ideal" insulin level becaus... |
|
| | | |||
